Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII (FVIII) Protein”

768 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 768 results

Testing effectiveness (Phase 2)Study completedNCT00994929
What this trial is testing

Efficacy and Safety of IL-11 in DDAVP Unresponsive

Who this might be right for
Hemophilia AVon Willebrand Disease
University of Pittsburgh 9
Not applicableApproved For MarketingNCT03154437
What this trial is testing

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

Who this might be right for
Hemophilia A
Genentech, Inc.
Not applicableUnknownNCT02581735
What this trial is testing

Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia

Who this might be right for
Haemophilia
Real Fundación Victoria Eugenia 40
Not applicableUnknownNCT00324493
What this trial is testing

Musculoskeletal Function in Hemophilia

Who this might be right for
Hemophilia
Christian Medical College, Vellore, India 250
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Not applicableStudy completedNCT00969319
What this trial is testing

Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America

Who this might be right for
Blood Coagulation DisordersHemophilia A
Bayer 105
Not applicableStudy completedNCT00178607
What this trial is testing

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

Who this might be right for
Hemophilia A
The University of Texas Health Science Center, Houston 99
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableStudy completedNCT04953000
What this trial is testing

Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

Who this might be right for
Hemophilia A
Takeda 94
Not applicableStudy completedNCT03299699
What this trial is testing

Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia

Who this might be right for
Severe Haemophilia
Assistance Publique Hopitaux De Marseille 30
Not applicableUnknownNCT02061033
What this trial is testing

Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease

Who this might be right for
Hemophilia AHemophilia BVon Willebrand's Disease
Karolinska University Hospital 180
Early research (Phase 1)Study completedNCT01562587
What this trial is testing

Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 18
Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 31
Not applicableStudy completedNCT03623295
What this trial is testing

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

Who this might be right for
Hemophilia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 304
Not applicableStudy completedNCT01318707
What this trial is testing

Biomarkers Serum Collection Methodology Pilot Study

Who this might be right for
Hemophilia A
Georgetown University 20
Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60
Post-approval studies (Phase 4)Looking for participantsNCT06864975
What this trial is testing

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

Who this might be right for
Hemophilia a with Inhibitor
Runhui WU 110
Early research (Phase 1)Looking for participantsNCT06703606
What this trial is testing

Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Who this might be right for
Severe Hemophilia A
Pfizer 15
Not applicableStudy completedNCT02870452
What this trial is testing

Effectiveness of Psychological Interventions in Haemophilia

Who this might be right for
Haemophilia
University of Minho 20
Large-scale testing (Phase 3)Study completedNCT01945593
What this trial is testing

BAX 855 Continuation

Who this might be right for
Hemophilia A
Baxalta now part of Shire 218
Load More Results